Trial ID: | L6258 |
Source ID: | NCT00394407
|
Associated Drug: |
Sliding Scale Regular Insulin
|
Title: |
Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes
|
Acronym: |
|
Status: |
COMPLETED
|
Study Results: |
NO
|
Results: |
|
Conditions: |
Diabetes|Hyperglycemia
|
Interventions: |
DRUG: sliding scale regular insulin|DRUG: glargine basal insulin and glulisine prandial insulin
|
Outcome Measures: |
Primary: blood glucose control, Differences in BG control will be assessed between the 2 arms acqhs and as needed for those patients hospitalized on the non-medical floors, During hospitalization | Secondary: frequency of hypoglycemia, assess differences in the frequency of hypoglycemia between the 2 study arms, during the hospitalization|frequency of severe hyperglycemia (BG > 400 mg/dl),, evaluate differences in severe hyperglycemia between the 2 study arms, during the hospitalization|length of hospital stay, differences in LOS between study arms, during hospitalization|inflammatory markers, C-reactive protein, interleukin-6, and tumor necrosis factor, during hospitalization
|
Sponsor/Collaborators: |
Sponsor: Emory University | Collaborators: Sanofi|University of Miami
|
Gender: |
FEMALE
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
PHASE4
|
Enrollment: |
130
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
Start Date: |
2005-09
|
Completion Date: |
2006-06
|
Results First Posted: |
|
Last Update Posted: |
2013-11-21
|
Locations: |
University of Miami School of Medicine, Coral Gables, Florida, 33124, United States
|
URL: |
https://clinicaltrials.gov/show/NCT00394407
|